Ovid Therapeutics, Inc. (OVID)
1.59
-0.03
(-1.85%)
USD |
NASDAQ |
Dec 11, 11:08
Ovid Therapeutics Cash from Investing (Quarterly): 5.053M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AnaptysBio, Inc. | 103.28M |
| Ionis Pharmaceuticals, Inc. | 91.34M |
| MannKind Corp. | -25.06M |
| Cassava Sciences, Inc. | -0.08M |
| Cidara Therapeutics, Inc. | -176.47M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.87M |
| Cash from Financing (Quarterly) | 0.015M |
| Free Cash Flow | -37.93M |
| Free Cash Flow Per Share (Quarterly) | -0.181 |
| Free Cash Flow to Equity (Quarterly) | -12.54M |
| Free Cash Flow to Firm (Quarterly) | -12.87M |
| Free Cash Flow Yield | -33.57% |